SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-010152
Filing Date
2023-03-31
Accepted
2023-03-31 15:03:21
Documents
63
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1518881
2 form10-k_001.jpg GRAPHIC 32530
3 form10-k_002.jpg GRAPHIC 16992
4 form10-k_003.jpg GRAPHIC 28110
5 form10-k_004.jpg GRAPHIC 23881
6 ex4-1.htm EX-4.1 38711
7 ex21-1.htm EX-21.1 3428
8 ex31-1.htm EX-31.1 20467
9 ex31-2.htm EX-31.2 20691
10 ex99-1.htm EX-99.1 40877
11 ex99-2.htm EX-99.2 36114
12 ex99-3.htm EX-99.3 18331
  Complete submission text file 0001493152-23-010152.txt   5531841

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE ptix-20221231.xsd EX-101.SCH 33907
14 XBRL CALCULATION FILE ptix-20221231_cal.xml EX-101.CAL 48182
15 XBRL DEFINITION FILE ptix-20221231_def.xml EX-101.DEF 166218
16 XBRL LABEL FILE ptix-20221231_lab.xml EX-101.LAB 323512
17 XBRL PRESENTATION FILE ptix-20221231_pre.xml EX-101.PRE 241443
57 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 552299
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12555 | Film No.: 23786889
SIC: 2834 Pharmaceutical Preparations